Ya-Lin Huang Selected Research

UBP 310

1/2019

Vascular endothelial growth factor increases the function of calcium-impermeable AMPA receptor GluA2 subunit in astrocytes via activation of protein kinase C signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ya-Lin Huang Research Topics

Disease

5	Ischemia 07/2012 - 08/2002
3	Neoplasms (Cancer) 05/2014 - 06/2000
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2008 - 08/2002
2	Chemical and Drug Induced Liver Injury 01/2023 - 02/2022
2	Stroke (Strokes) 07/2012 - 12/2008
2	Infarction (Infarctions) 10/2002 - 08/2002
2	Transient Ischemic Attack 10/2002 - 08/2002
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024
1	Adenocarcinoma 01/2024
1	Skin Diseases (Skin Disease) 05/2023
1	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 05/2023
1	Liver Failure 01/2023
1	Liver Diseases (Liver Disease) 02/2022
1	Hypoxia (Hypoxemia) 01/2019
1	Bone Neoplasms (Bone Cancer) 12/2012
1	Hyperalgesia 12/2012
1	Pain (Aches) 12/2012
1	Brain Injuries (Brain Injury) 07/2012
1	Brain Ischemia (Cerebral Ischemia) 08/2002
1	Inflammation (Inflammations) 08/2002
1	Hepatocellular Carcinoma (Hepatoma) 06/2000
1	Hyperplasia 06/2000
1	Carcinoma (Carcinomatosis) 06/2000

Drug/Important Bio-Agent (IBA)

2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 10/2002
2	CateninsIBA 05/2014 - 07/2012
2	DNA (Deoxyribonucleic Acid)IBA 08/2002 - 06/2000
2	Messenger RNA (mRNA)IBA 08/2002 - 08/2002
1	Dosage Forms (Dosage Form)IBA 01/2024
1	NanogelsIBA 01/2024
1	Gemcitabine FDA Link 01/2024
1	Collagen Type VIIIBA 05/2023
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2023
1	Tamoxifen FDA LinkGeneric 01/2023
1	UBP 310IBA 01/2019
1	6-Cyano-7-nitroquinoxaline-2,3-dione (6 Cyano 7 nitroquinoxaline 2,3 dione)IBA 01/2019
1	N-Methylaspartate (NMDA)IBA 01/2019
1	CalciumIBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	AMPA Receptors (AMPA Receptor)IBA 01/2019
1	Kainic Acid Receptors (Kainate Receptor)IBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 12/2012
1	lipoxin A4IBA 12/2012
1	lipoxin B4IBA 12/2012
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2012
1	CytokinesIBA 12/2012
1	LipoxinsIBA 12/2012
1	Small Interfering RNA (siRNA)IBA 07/2012
1	Caspase 3 (Caspase-3)IBA 12/2008
1	CaspasesIBA 12/2008
1	Amyloid beta-PeptidesIBA 12/2008
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 12/2008
1	OligodeoxyribonucleotidesIBA 10/2002
1	NestinIBA 08/2002
1	gamma-Aminobutyric Acid (GABA)IBA 08/2002
1	CarrageenanIBA 08/2002
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 08/2002
1	5-HT1A Serotonin ReceptorIBA 08/2002
1	MelatoninIBA 08/2002
1	Serotonin (5 Hydroxytryptamine)IBA 08/2002
1	IodidesIBA 06/2000
1	ParaffinIBA 06/2000
1	ChromatinIBA 06/2000
1	Fluorescent Dyes (Fluorescent Probes)IBA 06/2000
1	1,1'- ((4,4,7,7- tetramethyl)- 4,7- diazaundecamethylene)bis- 4- (3- methyl- 2,3- dihydro(benzo- 1,3- oxazole)- 2- methylidene)quinolinium (YOYO)IBA 06/2000

Therapy/Procedure

4	Lasers (Laser) 10/2002 - 06/2000
3	Therapeutics 01/2024 - 02/2022